About N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide
N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide (PubChem CID 712224) has the molecular formula C13H11N5O4S
and a molecular weight of 333.33 g/mol. Its IUPAC name is N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide.
Analyze N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide?
The IUPAC name of N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide (CID 712224) is N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide.
What is the SMILES notation for N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide?
The canonical SMILES for N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide is CC(=O)Nc1nonc1NC(=O)CSc1nc2ccccc2o1.
What is the InChIKey of N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide?
The InChIKey is GKWRLSCSDDSZCN-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H11N5O4S/c1-7(19)14-11-12(18-22-17-11)16-10(20)6-23-13-15-8-4-2-3-5-9(8)21-13/h2-5H,6H2,1H3,(H,14,17,19)(H,16,18,20).
What are the key properties of N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide?
N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide has a molecular weight of 333.33 g/mol, XLogP of 1.90, 5 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-acetamido-1,2,5-oxadiazol-3-yl)-2-(1,3-benzoxazol-2-ylsulfanyl)acetamide is sourced from PubChem (CID 712224), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).